AFT Pharma strikes licensing deal with Swiss company to sell Maxigesic in 69 countries

Fiona Rotherham
Sun, 28 Feb 2016

By Fiona Rotherham Feb. 29 (BusinessDesk) -  AFT Pharmaceuticals has reached agreement with privately-owned Swiss headquartered multinational pharmaceutical company Acino Pharma AG to out-license the Auckland drug-maker’s main product, the patented combination painkiller Maxigesic to a further 69 countries. The shares rose.  The agreement is to sell all oral dose forms of Maxigesic and Maxigesic 1V in four geographic regions – Saudi Arabia and Yemen, Central America and the Caribbean, Africa, and North Africa and Levant. AFT markets more...
Opinion
PATTRICK SMELLIE: What do the Nats do now?
Pattrick Smellie | Tue, 14 Jul 2020

Todd Muller's only job as National Party leader was to lose the election better than it seemed Simon Bridges was destined to do. Whoever replaces Muller has an even simpler task: save as much of th...

Listed Companies
Huljich family sells 25% of Pushpay stake
Dan Brunskill | Tue, 14 Jul 2020

The Huljich family has sold a quarter of its cornerstone stake in Pushpay Holdings, one of the rising software company stars. The 14.4 million shares were sold for $123.8 million, or $8.60 per shar...

Property
Housing market rebounds sharply; caution required
Jenny Ruth | Tue, 14 Jul 2020

The housing market bounded out of lockdown last month with sales volumes the highest for June in four years and prices nationally up 8.6 percent from a year earlier. The Real Estate Institute's lat...

The role of private equity in the wake of COVID-19

As local covid-19 restrictions ease, a new business cycle is beginning in New Zealand.